Medicine and Dentistry
Radioisotope
100%
In Vitro
100%
Radiopharmaceutical
68%
Tetraxetan
56%
External Beam Radiotherapy
50%
Gallium 67
50%
Plasmid
50%
Lutetium 177
50%
Combination Therapy
50%
Somatostatin Receptor
50%
Indium 111
37%
Plasmid DNA
37%
Radionuclide Therapy
37%
Auger Electron Spectroscopy
29%
Hydroxyurea
19%
Micrometastasis
16%
Neoplasm
16%
Dosimetry
16%
Circulating Tumor Cell
16%
Oncology
16%
Radiation Therapy
16%
3 Aminopicolinaldehyde Thiosemicarbazone
15%
Gemcitabine
15%
Incubation
13%
DNA Determination
12%
Biological Activity
12%
Cell Size
11%
Monotherapy
7%
Incubation Time
6%
DNA Damage
6%
Caesium-137
6%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
6%
Gel Electrophoresis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Tetraxetan
56%
Radioisotope
53%
Gallium 67
50%
Combination Therapy
50%
Somatostatin Receptor
50%
Lutetium 177
50%
Indium 111
37%
Plasmid DNA
37%
Hydroxycarbamide
19%
3 Aminopicolinaldehyde Thiosemicarbazone
15%
Gemcitabine
15%
Monotherapy
7%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
6%
Incubation Time
6%
Cesium 137
6%
Gel Electrophoresis
6%
Biochemistry, Genetics and Molecular Biology
Somatostatin Receptor
50%
Hydroxycarbamide
19%
Gemcitabine
15%
Cell Size
11%
